Evaluating empirical bounds on complex disease genetic architecture.
about
Rare-variant association analysis: study designs and statistical testsUnderstanding rare and common diseases in the context of human evolutionStrategies for Imputing and Analyzing Rare Variants in Association StudiesGenomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolateThe genetic architecture of type 2 diabetesExposing the exposures responsible for type 2 diabetes and obesity.Simulation of Finnish population history, guided by empirical genetic data, to assess power of rare-variant tests in Finland.Variant association tools for quality control and analysis of large-scale sequence and genotyping array dataThe role of functional data in interpreting the effects of genetic variationThe impact of rare and low-frequency genetic variants in common diseaseThe impact of population demography and selection on the genetic architecture of complex traits.Most genetic risk for autism resides with common variation.Genetic simulation tools for post-genome wide association studies of complex diseasesJumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.A joint history of the nature of genetic variation and the nature of schizophrenia.The effect of paternal age on offspring intelligence and personality when controlling for paternal trait levelRare variant association studies: considerations, challenges and opportunities.A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring StudyGenetics of type 2 diabetes-pitfalls and possibilities.The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex diseaseContrasting genetic architectures in different mouse reference populations used for studying complex traits.Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17.Recent advances in understanding the genetic architecture of type 2 diabetesType 2 Diabetes Risk Allele Loci in the Qatari Population.A Model of Compound Heterozygous, Loss-of-Function Alleles Is Broadly Consistent with Observations from Complex-Disease GWAS Datasets.Explaining additional genetic variation in complex traitsA rare-variant test for high-dimensional data.Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family StudyMulti-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitisReflections on the Field of Human Genetics: A Call for Increased Disease Genetics TheoryEstimating the mutation load in human genomesCommon variants explain a large fraction of the variability in the liability to psoriasis in a Han Chinese population.Considerations for rare variants in drug metabolism genes and the clinical implications.Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond.How important are rare variants in common disease?An excess of risk-increasing low-frequency variants can be a signal of polygenic inheritance in complex diseases.Whole-genome sequencing approaches for conservation biology: advantages, limitations, and practical recommendations.An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes.The genetics of anxiety-related negative valence system traits.
P2860
Q26852733-085AA22C-6778-4BCA-9C22-090E8F4EAF88Q28067740-5429EBFA-3252-48D4-A9E8-35EA14FAFFCEQ28081028-6B4BD844-7659-453B-B484-29173F63240DQ28657831-D87556ED-C0B9-470F-9D17-2B6599905101Q29583824-B15D6511-20BC-43D0-968D-BFF7EFE79F0CQ30241246-3977050B-7BF1-4180-BB14-0AAFD13CAF1DQ30809578-9F0E60E5-103D-4ADB-B2CB-597C4F948A3DQ30813514-F4AF364F-712E-49B2-A435-F8E58BA5CBC0Q31018970-C91ECD04-48CE-4A25-9E78-BD18646EDFCFQ33613854-F052CB63-7AAC-4181-AFE7-A07A8D6E55F6Q33686100-5FFB8AE3-4BDA-45A0-B0E3-3EED99996464Q34063817-B6D34C23-2A5A-47C1-A2FC-3C428A83AF0DQ34734512-F412DE5D-0421-4ADC-9DBE-B533512C2BF0Q34879739-C78989FC-70A0-40CA-9EEC-28EFC796DC4BQ35054408-B6FBDCBF-4CCE-46F5-92A3-27230AB2BF2DQ35108676-83ADFF7E-3399-4169-BDC1-FF57071C719FQ35110309-7813FB22-4545-49F9-8055-1C3286F31F02Q35118206-25401603-7C01-468C-A0D3-2EC748810C6FQ35227765-F0D3E013-4DCA-4A81-97DE-5C77E3E81A53Q35612748-A57BA1D7-EFF8-40D6-8931-B85B4A281D96Q35664102-4A0E7108-E1A4-46C7-B13D-6C4C52E9F943Q35688980-12C218D4-53DA-4389-959F-2E9C9DAF4C60Q36065329-5044E39C-77A8-42A1-A565-E8E274751854Q36068863-269B1BD0-B273-4FD5-BBF5-03A6BD87F0F1Q36253742-8269B914-A15E-4D96-860D-6D88B92B4BA0Q36264669-AD8704A3-C12C-4108-84F3-51FAA739273FQ36379034-CF295492-5C91-463A-905B-8A7BC94D160AQ36515907-16CB9F35-85EC-4CC9-928A-4B5E2D9EFD41Q36580238-F7B26817-2830-46B9-BEC7-6AF8D079B5F2Q36978721-F0F66120-15E6-4A99-B540-BEE41694C409Q37121904-FBF51522-5BA9-4B40-AC0A-A15F7C80FC0CQ37539800-5BD0DA22-6101-4E48-82A8-280E0775B491Q38199740-DF665E78-A906-4683-B7D3-3407D43B5CC7Q38214522-77C68AE6-80BE-4458-97CF-E51465042257Q38227463-D0B4E598-981C-4C59-9320-6C8B4C5D1531Q38261971-AD581D9E-CA46-4941-9DA2-DA0021E12831Q38651500-4A3BD477-CD2A-411A-98FD-0545879AA10DQ38752732-D809358C-CB69-4C7A-A074-959561F05958Q38808702-3D495384-AC34-4F8F-82C4-DCE4A10581E5Q38838410-5D1A73C8-F201-4189-8E18-F3CD4BA3DEAA
P2860
Evaluating empirical bounds on complex disease genetic architecture.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Evaluating empirical bounds on complex disease genetic architecture.
@en
Evaluating empirical bounds on complex disease genetic architecture.
@nl
type
label
Evaluating empirical bounds on complex disease genetic architecture.
@en
Evaluating empirical bounds on complex disease genetic architecture.
@nl
prefLabel
Evaluating empirical bounds on complex disease genetic architecture.
@en
Evaluating empirical bounds on complex disease genetic architecture.
@nl
P2093
P2860
P356
P1433
P1476
Evaluating empirical bounds on complex disease genetic architecture.
@en
P2093
GoT2D Consortium
Jason Flannick
Shamil Sunyaev
Vineeta Agarwala
P2860
P2888
P304
P356
10.1038/NG.2804
P407
P577
2013-10-20T00:00:00Z